Mr. Speaker, we already told the member that we are willing to move this to committee, but it does not mean we should forego our voices here in the House in the debate on the issues.
We all know full well that, once we are at committee, even though the minister says she is willing to look at amendments, all too often the government is willing to push forward without amendments because it has the majority. We want to make sure the Conservatives fully understand that we think this is a great bill and it is moving in the right direction, but it is imperative that there be amendments to it.
My question for the member, if he were able to answer, would be how this new legislation would improve the prevention of adverse drug reactions when it does nothing to change Health Canada's follow-up on adverse reaction reports.